Use of an interferon-gamma based assay to assess bladder cancer patients treated with intravesical BCG and exposed to tuberculosis

Abstract

OBJECTIVE: Compare the QuantiFERON-TB Gold In-Tube (QFT) assay and the tuberculin skin test (TST) in bladder cancer patients receiving high dose BCG therapy (BCG patients). DESIGN AND METHODS: BCG patients and healthy visitors, both exposed to tuberculosis, were screened with a TST and QFT.

Authors

Silverman MS; Reynolds D; Kavsak PA; Garay J; Daly A; Davis I

Journal

Clinical Biochemistry, Vol. 40, No. 12, pp. 913–915

Publisher

Elsevier

Publication Date

August 2007

DOI

10.1016/j.clinbiochem.2007.04.006

ISSN

0009-9120

Associated Experts

Peter Kavsak

Professor, Faculty of Health Sciences

Visit profile

Labels